INTRODUCTION
============

It is well known that the proper function of a protein strictly depends on its native conformation, but protein folding is a fundamentally error-prone process. The endoplasmic reticulum (ER) is the cellular port of entry for secretory and membrane proteins to enter the secretory pathway and is a folding compartment for proteins to attain their native conformations through interactions with molecular chaperones, sugar-binding lectins, and folding enzymes ([@B27]). Misfolded proteins not only lead to functional deficiency but also induce dominant-negative and cellular toxicity effects, and it is thus essential that the ER should possess several highly stringent protein quality control mechanisms to closely monitor the folding process, allowing export of only correctly folded proteins to their final destinations but retaining incompletely/mis-folded proteins for additional rounds of chaperone-assisted folding. A high-efficient ER-mediated protein quality control (ERQC) system can also differentiate terminally misfolded proteins from folding intermediates and/or reparable misfolded proteins, stopping the futile folding cycles of the former proteins and eliminating them via a multistep degradation process widely known as ER-associated degradation (ERAD) that involves ubiquitination, retrotranslocation, and cytosolic proteasome ([@B88]). Our current understanding of the eukaryotic ERQC/ERAD system derived largely from studies in yeast and mammalian cells. However, recent genetic, biochemical, and cell biological studies in the reference plant *Arabidopsis thaliana* and other model plant species not only identified homologous ERQC/ERAD components but also revealed evolutionarily conserved features as well as unique aspects of the plant ERQC/ERAD mechanisms ([@B33]; [@B42]; [@B41]), especially their connections with the stress tolerance and plant defense pathways.

*N*-GLYCAN-BASED ER RETENTION MECHANISM
=======================================

Many secretory and membrane proteins are co-translationally glycosylated when entering the ER ([@B1]). The so-called N-linked glycosylation occurs on the asparagine (Asn or N) residues within the Asn-X-Ser/Thr sequons (X indicating any amino acid except proline while Ser/Thr denoting serine/threonine residue) of a nascent polypeptide. This reaction is catalyzed by the enzyme oligosaccharyltransferase (OST), an integral membrane protein complex that transfers a preassembled oligosaccharide precursor Glc~3~Man~9~GlcNac~2~ (Glc, Man and GlcNac denoting glucose, mannose and *N*-acetylglucosamine, respectively) from a membrane-anchored dolichylpyrophosphate (DolPP) carrier to the Asn residue (**Figure [1](#F1){ref-type="fig"}**; [@B66]). The assembly of Glc~3~Man~9~GlcNac~2~ involves a series of highly specific asparagine-linked glycosylation (ALG) proteins that sequentially add a monosaccharide onto the DolPP linker or a DolPP-linked oligosaccharide precursor ([@B1]; **Figure [1A](#F1){ref-type="fig"}**). The structure of a N-linked glycan plays an important role in the protein folding and quality control ([@B2]). Immediately after transferring of Glc~3~Man~9~GlcNac~2~ to an Asn residue, the terminal and middle Glc residues are removed sequentially by glucosidase I (GI) and glucosidase II (GII), producing a monoglucosylated *N*-glycan, GlcMan~9~GlcNac~2~, which is recognized by the ER chaperone-like lectins, a membrane-anchored calnexin (CNX) and its ER luminal homolog calreticulin (CRT; [@B10]; **Figure [2](#F2){ref-type="fig"}**). The high-specificity high-affinity binding between GlcMan~9~GlcNac~2~ and CNX/CRT is crucial for folding a nascent polypeptide as CNX/CRT can recruit other ER-chaperones and folding enzymes, including protein disulfide isomerases (PDIs) essential for generating inter/intra-molecular disulfide bonds. The removal of the remaining Glc residue by GII releases the nascent glycoprotein from CNX/CRT, thus terminating its folding process ([@B10]). If the protein folds correctly, it will be transported out of the ER to reach its final destination. However, if the protein fails to attain its native conformation, it will be recognized by UDP-glucose:glycoprotein glucosyltransferase (UGGT), an ER-resident folding sensor consisting of a large non-conserved N-terminal domain presumably involved in recognizing non-native conformations and a smaller highly conserved C-terminal catalytic domain capable of catalyzing a glucosyltransferase reaction using uridyl diphosphate-glucose (UDP-Glc) as a substrate ([@B16]). As a result, a single Glc is added back to deglucosylated *N*-glycans of the incompletely/mis-folded protein, permitting its reassociation with CNX/CRT and their associated proteins for another round of assisted folding. The alternate reactions of GII and UGGT drive many cycles of dissociation and reassociation of CNX/CRT with an incompletely/mis-folded glycoprotein \[widely known as the CNX/CRT cycle ([@B28])\], till the protein attains its native conformation (**Figure [2](#F2){ref-type="fig"}**). It is worthy to mention that the budding yeast (*Saccharomyces* cerevisiae), which is widely used for studying the ERAD process, lacks the CNX/CRT-UGGT system due to the presence of a catalytically inactive UGGT homolog ([@B64]).

![**(A)** Stepwise assembly of *N*-glycan precursor on the ER membrane. The assembly of the *N*-glycan precursor starts at the cytosolic face of the ER membrane by adding two GlcNAc and five Man residues to the membrane-anchored Dol-PP linker. The resulting Dol-PP-Man~5~GlcNAc~2~ flips over into the ER lumen. Four Man residues are sequentially added to the flipped Dol-PP-Man~5~GlcNAc~2~ by three mannosyltransferases, ALG3, ALG9 (known as EBS3 in *Arabidopsis*) and ALG12 (known as EBS4 in *Arabidopsis*) with the ALG9 catalyzing two reactions of adding the terminal α1,2 Man residues on the middle and right branches. Three Glc residues are subsequently added to the right branch, generating the 14-sugar precursor, Dol-PP-Glc~3~Man~9~GlcNAc~2~. Two α1,6 Man residues are marked by brown and salmon color. The Dol-PP linker and different sugar residues are indicated. **(B)** The structure of N-linked Glc~3~Man~9~GlcNac~2~ glycan with three dimannose branches (branch A, B and C). Lower case letters inside sugar residues represent the order of sugar addition. The sugar linkage bonds and enzymes (GI, GII) that remove the three Glc residues are indicated. Figure adapted from [@B34].](fpls-05-00162-g001){#F1}

![**An overview of the ERQC/ERAD system**. Two Glc residues on the *N*-glycan of a nascent polypeptide are rapidly trimmed by GI and GII right after being transferred from the Dol-PP-linker. The resulting monoglucosylated *N*-glycans bind the two ER lectins CNX and CRT chaperone-assisted folding. The removal of this last Glc by GII releases a mature polypeptide from CNX/CRT. A correctly folded protein can leave the ER while an incompletely/mis-folded glycoprotein is recognized by UGGT (known as EBS1 in *Arabidopsis*) that adds back a Glc residue to the A branch, permitting its reassociation with CNX/CRT. A glycoprotein that fails to gain its native structure within a certain time window is removed from the folding cycle via sequential trimming of the two terminal α1,2 Man residues of the B and C branch by MNS1 (an ER-localized α1,2-Mannosidase, known as MNS3 in *Arabidopsis*) and Htm1/EDEM. A terminally misfolded glycoprotein with α1,6 Man-exposed glycan is selected to enter the ERAD pathway.](fpls-05-00162-g002){#F2}

The *Arabidopsis* genome encodes only one UGGT homolog, and its physiological function was inadvertently found in a study for identifying additional signaling proteins of the plant steroid hormones, brassinosteroids (BR; [@B45]). A genetic screening for extragenic suppressors of an *Arabidopsis* dwarf mutant *brassinosteroid-insensitive 1-9* (*bri1-9*) led to the discovery of *Arabidopsis* UGGT (also known as EBS1 for EMS mutagenized bri1 suppressor 1; [@B45]). BRI1 is a cell surface-localized leucine-rich-repeat receptor-like-kinase that function as a BR receptor and contains a single transmembrane domain and 14 putative N-glycosylation sites in its N-terminal extracellular domain ([@B53]). The mutant bri1-9, carrying a Ser662-Phe mutation in the BR-binding domain ([@B70]), was found to be retained in the ER by an EBS1/AtUGGT-dependent mechanism and subsequently degraded by a plant ERAD process ([@B45]; [@B34]). Loss-of-function mutations in EBS1/AtUGGT compromise such an ER-retention mechanism and allow some bri1-9 proteins to escape from the ER to reach the plasma membrane, resulting in phenotypic suppression of the dwarfism of the *bri1-9* mutant. The same genetic screen also identified CRT3 ([@B44]), a unique member of the *Arabidopsis* CNX/CRT family consisting of two CNXs and three CRTs, which actually retains bri1-9 via the CRT3-GlcMan~9~GlcNac~2~ binding. Both UGGT and CRT3 were also identified from two other independent genetic screens aiming to identify key regulators of the plant innate immune response to a bacterial translational elongation factor EF-Tu ([@B54]; [@B85]). Interestingly, while loss-of-function mutations in AtUGGT/CRT3 led to regaining partial sensitivity to BRs, *atuggt/crt3* mutants were insensitive to elf18, a biologically active epitope of EF-Tu. Further studies showed that both UGGT and CRT3 are absolutely required for the correct folding of EFR (EF-Tu Receptor; [@B84]), a BRI1-like receptor-like kinase that binds elf18/EF-Tu to initiate a plant defense process ([@B104]). The importance of *N*-glycan-mediated folding control was further supported by discoveries that loss-of-function mutations in STT3A, a OST subunit, and GII resulted in significant reduction of the EFR protein abundance, presumably caused by incomplete folding and subsequent degradation ([@B60]; [@B30]; [@B97]).

In addition to the glycan-dependent ER retention system, the ER is equipped with additional retention systems to prevent export of misfolded proteins, especially those non-glycosylated ones. One system uses the family of ER-localized HSP70 proteins (known as BiPs), which have a N-terminal ATP-binding domain and a C-terminal substrate-binding domain that recognizes and binds to exposed hydrophobic patches of incompletely/mis-folded proteins in an ATP-dependent manner ([@B9]). The *Arabidopsis* has three BiP homologs, AtBiP1, AtBiP2 and AtBiP3, all of which were known to exhibit higher levels of gene expression under ER stresses ([@B92]). In *Arabidopsis*, BiPs were shown to bind both bri1-9 and bri1-5, another mutant variant of BRI1 carrying a Cys69Tyr mutation that destroys a disulfide bridge crucial for the structural integrity of the BR receptor, and were thought to contribute for the ER retention of the two mutant BR receptors ([@B45]; [@B35]). BiPs and their associated factors ERdj3B (an *Arabidopsis* ER-localized DNAJ homolog) and SDF2 (the *Arabidopsis* homolog of the murine stromal cell-derived factor 2) are also involved in the biogenesis/folding control of EFR ([@B68]). BiPs were also known to interact with the orphan heavy chain of a murine IgG1 antibody or an assembly defective form of the trimeric vacuolar storage protein phaseolin in transgenic tobacco plants ([@B74]; [@B71]). Another glycan-independent ER retention mechanism relies on mixed disulfide bridges between incompletely/mis-folded proteins with PDIs and related ER-localized oxidoreductases ([@B83]; [@B3], [@B4]). The *Arabidopsis* genome encodes 13 PDI-like proteins ([@B40]), none of which has been implicated in retaining misfolded proteins. However, a recent study on bri1-5 carrying an orphan cysteine residue (Cys62) suggested involvement of a thiol-mediated retention system in keeping the mutant BR receptor in the ER ([@B35]). Further biochemical studies are needed to verify this prediction and to identify one or more PDIs that form the predicted mixed disulfide bridge with the orphan Cys62 residue.

MARKING OF A TERMINALLY MISFOLDED GLYCOPROTEIN FOR ERAD
=======================================================

A protein that fails to attain its native conformation within a given time window is eliminated by ERAD ([@B96]). One of the key events in ERQC is to terminate a futile folding cycle and to deliver an irreparable misfolded protein into the ERAD pathway. Although little is known about the marking mechanism for irreparable non-glycosylated ERAD clients, recent studies indicated that removal of the terminal α1,2-Man residue from the C-branch of *N*-glycan (**Figure [2](#F2){ref-type="fig"}**), catalyzed by homologous to mannosidase 1 (Htm1) in yeast and ER-degradation enhancing α-mannosidase-like proteins (EDEMs) in mammals, is required for generating the ERAD signal, an exposed α1,6 Man residue on an N-linked glycan ([@B79]; [@B14]; **Figure [1B](#F1){ref-type="fig"}**). The *Arabidopsis* genome encodes at least two homologs of the yeast Htm1/mammalian EDEMs \[known as MNS4 and MNS5 ([@B55])\], but their involvement in a plant ERAD process awaits functional investigation. Nevertheless, recent genetic screening for *Arabidopsis* mutants defective in ERAD of bri1-5/bri1-9 and subsequent molecular cloning and biochemical studies indicated that the glycan ERAD signal is well conserved in plants ([@B34], [@B36]). Loss-of-function mutations in either EBS3 and EBS4 (homologs of the yeast/mammal ALG9 and ALG12, respectively) prevent complete assembly of the *N*-glycan precursor (**Figure [1](#F1){ref-type="fig"}**), resulting in glycosylation of the two ER-retained mutant BR receptor with truncated *N*-glycan lacking the α1,6-Man residue that would function as the ERAD signal and consequential inhibition of ERAD of bri1-5/bri1-9. In contrast, forcing the addition of the missing α1,6 Man residue to Dol-PP-Man~6~GlcNAc~2~ by overexpression of EBS4/ALG12 in an *Arabidopsis ebs3/alg9 bri1-9* mutant promoted the ERAD of bri1-9 (**Figure [1A](#F1){ref-type="fig"}**; [@B36]). Similarly, the ERAD of bri1-9 was presumably accelerated when its N-linked glycans carried a different exposed α1,6 Man residue (the inner α1,6 Man; [@B36]) caused by a loss-of-function mutation in ALG3 that adds an α1,3 Man to the inner α1,6-Man ([@B31]; [@B46]; **Figure [1A](#F1){ref-type="fig"}**). The exposed inner α1,6 Man residue was shown to function as an alternative ERAD signal in both yeast and mammalian cells ([@B14]; [@B38]).

RECRUITMENT OF ERAD SUBSTRATES
==============================

The *N*-glycan ERAD signal is decoded by one or two ER luminal lectins, osteosarcoma 9 (OS9, also known as Yos9 in yeast) and XTP3-B ([@B102]; **Figure [3](#F3){ref-type="fig"}**). Yos9 and its mammalian homologs contain the mannose-6-phosphate receptor homology (MRH) domain that specifically recognizes and binds *N*-glycans with an exposed α1,6 Man residue ([@B39]). In addition to OS-9/Yos9, selection of an ERAD client requires another ER resident protein, Hrd3 (HMG-CoA reductase degradation 3) in yeast and Sel1L (Suppressor of lin-12-Like) in mammals ([@B32]), a type I transmembrane protein with a large ER luminal domain consisting of multiple copies of the tetratricopeptide repeat motif. It was believed that Hrd3/Sel1L, exhibiting high affinity binding to exposed hydrophobic amino acid residues on misfolded proteins, makes the initial selection of a potential ERAD client, which is subsequently inspected by OS-9/Yos9 for the presence of an *N*-glycan ERAD signal ([@B17]; [@B26]; **Figure [3](#F3){ref-type="fig"}**). Such a bipartite ERAD signal of a misfolded domain plus an α1,6-Man-exposed *N*-glycan ensures degradation of only terminally misfolded glycoproteins but not folding intermediates carrying *N*-glycans with no exposed α1,6 Man residue.

![**A model of ERAD system**. An ERAD client that has lesion in membrane-embedded segment (ERAD~M~) or in ER lumen region (ERAD~L~) is recruit by Hrd3 (EBS5 in *Arabidopsis*) and Yos9 (EBS6/OS9 in *Arabidopsis*) to the membrane-anchored E3 ligase Hrd1 (AtHrd1A and AtHrd1B in *Arabidopsis*) complex that also contains Cue1, Ubc6 (UBC32 in *Arabidopsis*), Usa1 and Der1. An ERAD substrate with a folding lesion in the cytosolic domain (ERAD~C~ is recruited to a different ER membrane-anchored E3 ligase complex that contains Doa10 and Ubc6 (or Cue1/Ubc7). The two E3 ligase complexes share similar components on the cytosolic side of the ER membrane, including the substrate-extracting Cdc48-Ufd1-Npl4 trimeric complex and its membrane recruitment factor Ubx2 (one or more AtPUX proteins in *Arabidopsis*). An extracted polyubiquitinated ERAD substrate is processed by Ufd2, Ufd3, Otu1, and/or Png1 (AtPNG1 in *Arabidopsis*), delivered to the cytosolic proteasome with help of Dsk2 and Rad23, and eventually proteolyzed by the 26S proteasome.](fpls-05-00162-g003){#F3}

The *Arabidopsis* genome has two *Hrd3/Sel1L* homologous genes, *AtSel1A* (also known as *EBS5 or HRD3A* or) and *AtSel1B* (also known as *HRD3B,* an apparent pseudogene) and just one *OS9/Yos9* homolog, *AtOS9* (also known as *EBS6*; [@B57]; [@B90], [@B91]; [@B43]). AtSel1A/EBS5 complemented the ERAD-defect of the yeast Δ*hrd3* mutant assayed by ERAD of a mutant variant of carboxypeptidase Y (CPY\*; [@B90]), a commonly used ERAD substrate for many ERAD studies in yeast. By contrast, AtOS9 failed to rescue the defective ERAD of CPY\* when expressed in a Δ *yos9* yeast strain ([@B43]). Interestingly, a chimeric AtOS9-Yos9 protein consisting of the full-length AtOS9 and the Yos9's C-terminal region (amino acids of 277--542) promoted CPY\* degradation in Δ *yos9* yeast cells ([@B43]), suggesting that the MRH domain is interchangeable but the Yos9's C-terminal domain might be crucial for interacting with other components of the yeast ERAD machinery. Loss-of-function mutations in either AtSel1A/EBS5 or AtOS9/EBS6 inhibit ERAD of bri1-5, bri1-9, misfolded EFR (in an *ebs1/uggt* mutant background), and/or the transgenically expressed MLO-1 ([@B57]; [@B90], [@B91]; [@B43]), a mutant variant of barley powdery resistance o (MLO) that carries a single amino acid change in the cytoplasmic region and was previously shown to be an ERAD substrate ([@B67]). As expected, AtSel1A/EBS5 and AtOS9/EBS6 physically interacted with bri1-9 or bri1-5 in a tobacco transient expression system or an *in vitro* pull-down assay ([@B43]; [@B91]). Consistent with what was known in yeast and mammalian cells, AtSel1A/EBS5 binds AtOS9/EBS and seems to be required for maintaining the stability of AtOS9/EBS6 ([@B43]; [@B91]). These results strongly suggested that the selection mechanism for a terminally misfolded glycoprotein for ERAD is conserved in *Arabidopsis*. It is important to point out that *Arabidopsis* mutants of AtSel1A/EBS6 or AtOS9/EBS6 are hypersensitive to NaCl-induced salt stress, suggesting a relationship between a cellular stress response and an environmental stress pathway ([@B57]; [@B43]). It is quite possible that environmental stresses lead to decreased folding efficiency and increased accumulation of misfolded proteins in the ER, which require a highly efficient ERAD system for their removal to maintain ER homeostasis.

UBIQUITINATION OF CHOSEN ERAD CLIENTS
=====================================

Hrd3/Sel1L and Yos9/OS9 not only select irreparable misfolded glycoproteins but also bring the chosen ERAD substrates to the membrane-anchored ERAD complexes responsible for ubiquitination and retrotranslocation. The central component of these ERAD complexes is a polytopic membrane protein with a RING finger-type ubiquitin ligase (E3) activity exposed to the cytosolic surface of the ER membrane, which not only ubiquitinates ERAD substrates but also connects to various ER luminal/cytosolic adapters ([@B32]). Yeast contains at least two distinct E3 ligases, 6 transmembrane-spanning Hrd1 (HMG-CoA reductase degradation) and 14-transmembrane-spanning Doa10 (Degradation of alpha2), that ubiquitinate three different types of ERAD substrates differing in the location of folding lesions: ERAD~L~ (lesion in the ER luminal area), ERAD~M~ (lesion in the transmembrane segment), and ERAD~C~ (lesion in the cytosolic domain; [@B95]; [@B12]). The Hrd1 complex ubiquitinates ERAD~L/M~ substrates while the Doa10 complex deals with ERAD~C~ clients. Mammals have at least 9 membrane-bound ERAD E3 ligases ([@B72]), including two Hrd1 homologs (HRD1 and gp78), one Doa10 homolog (TEB4), and several other RING-type E3 ligases such as RING membrane-anchor 1 (RMA1; [@B103]), whose founding member was initially discovered in *Arabidopsis* ([@B63]).

The *Arabidopsis* genome encodes two Hrd1 homologs (AtHrd1A and AtHrd1B; [@B90]; [@B42]), at least two Doa10 homologs (Doa10A/At4g34100 and Doa10B/At4g32670; [@B57]), and three homologs of RMA1, AtRMA1-AtRMA3 that were shown to be localized to the ER and exhibit *in vitro* E3 ubiquitin ligase activity ([@B89]; **Table [1](#T1){ref-type="table"}**), but it remains unclear if plants use distinct E3 ligases to removal different classes of ERAD substrates. Loss-of-function mutations in AtHrd1A or AtHrd1B had no detectable effect on bri1-5/bri1-9 degradation, but simultaneous elimination of the two Hrd1 homologs inhibited degradation of the two mutant BR receptors, indicating that AtHrd1A and AtHrd1B function redundantly in a plant ERAD pathway ([@B90]). By contrast, the role of the two Doa10 homologs in the plant ERAD pathway remains unknown. Two recent genetic studies revealed important regulator roles of Doa10A (also known as SUD1 for SUPPRESSOR OF DRY2 DEFECTS1 or CER9 for ECERIFERUM9) in the cuticle lipid biosynthesis and in controlling the activity but not the protein level of an *Arabidopsis* HMG-CoA reductase ([@B59]; [@B21]). Further studies are needed to determine if the *Arabidopsis* Doa10A is indeed involved in an ERAD pathway that regulates the protein abundance of key regulatory factors or metabolic enzymes involved in the cuticle lipid biosynthesis. Unlike yeast but similar to mammals, plants have additional membrane-anchored RING-type E3 ligases for ERAD. For example, the three *Arabidopsis* RMA1 homologs (Rma1H1) and a hot pepper (*Capsicum annuum*) Rma1H1 are involved in the degradation of a cell surface water channel to regulate its plasma membrane level ([@B52]). A recent study also suggested that a legume (*Medicago truncatula*) homolog of RMA1 seems to play a role in the regulation of biosynthesis of plant defense compounds, triterpene saponins that share the same biosynthetic precursors with sterols, through regulated degradation of HMG-CoA reductase ([@B78]).

###### 

A list of known/predicted components of the *Arabidopsis* ERAD system.

  Yeast/human gene name   *Arabidopsis* name   Accession number   Reference
  ----------------------- -------------------- ------------------ ------------------------
  Hrd1/HRD1               HRD1A                At3g16090          [@B90]
                          HRD1B                At1g65040          
  Hrd3/SEL1L              EBS5/HRD3A           At1g18260          [@B90]
                          HRD3B                At1g73570          
  Yos9/OS-9               EBS6/OS9             At5g35080          [@B43], [@B91]
  Der1/DERLIN             DER1                 At4g29330          [@B49]
                          DER2.1               At4g04860          [@B98], [@B47]
                          DER2.2               At4g21810          
  Ubc6/UBE2J1             UBC32                At3g17000          [@B51], [@B15]
                          UBC33                At5g50430          
                          UBC34                At1g17280          
  Htm1/EDEM               MNS4                 At5g43710          [@B55]
                          MNS5                 At1g27520          
  Doa10/TEB4              SUD1/CER9/DOA10A     At4g34100          [@B57], [@B21], [@B59]
                          DOA10B               At4g32670          
  RMA1                    RMA1                 At4G03510          [@B63], [@B89]
                          RMA2                 At4g28270          
                          RMA3                 At4g27470          
  Ubx2/ERASIN             PUX1                 At3g27310          [@B73], [@B82]
                          PUX2                 At2g01650          [@B93], [@B94]
                          PUX3                 At4g22150          
                          PUX4                 At4g04210          
                          PUX5                 At4g15410          
                          PUX6                 At3g21660          
                          PUX7                 At1g14570          
                          PUX8/SAY1            At4g11740          
                          PUX9                 At4g00752          
                          PUX10                At4g10790          
                          PUX11                At2g43210          
                          PUX12                At3g23605          
                          PUX13                At4g23040          
                          PUX14                At4g14250          
                          PUX15                At1g59550          
  Cdc48/p97               CDC48A               At3g09840          [@B81]
                          CDC48B               At2g03670          
                          CDC48C               At3g01610          
  Npl4/NPL4                                    At2g47970          
                                               At3g63000          
  Ufd1/UFD1               UFD1                 At2g21270          [@B25]
                                               At4g38930          
                                               At2g29070          
                                               At4g15420          
  Ufd2/UFD2                                    At5g15400          [@B5]
  Png1/PNG1               PNG1                 At5g49570          [@B20]
  Rad23/RAD23             RAD23A               At1g16190          [@B22]
                          RAD23B               At1g79650          
                          RAD23C               At3g02540          
                          RAD23D               At5g38470          

In a typical ubiquitination reaction, ubiquitin is attached to a substrate through a three-step process consisting of activation, conjugation, and ligation catalyzed by an ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and E3 ([@B75]). In yeast, the Hrd1/Doa10 E3 ligases work together with a membrane-anchored E2 (Ubc6) and two cytosolic E2s (Ubc1 and Ubc7) that are recruited to the ER membrane by an ER anchor protein Cue1 ([@B32]), which also activates both E2 and E3 ([@B7]; [@B65]). *Arabidopsis* has a total of 37 E2 enzymes ([@B51]), including one potential Ubc1 homolog (UBC27), three putative homologs of Ubc7 known to be the cognate E2 for Hrd1 (UBC7 UBC13, and UBC14), and three likely homologs of Ubc6 associated mainly with Doa10 (UBC32, UBC33, and UBC34 each having a predicted transmembrane domain at their C-termini; [@B57]), but our understanding of the roles of these potential ERAD-participating E2s in the plant ERAD process is extremely limited. One of the *Arabidopsis* Ubc6-like E2 gene, *UBC32*, was recently found to be induced by salt, drought, and ER stress ([@B15]). Interestingly, the *Arabidopsis ubc32* mutant seedlings are more tolerant whereas *UBC32*-overexpressing transgenic *Arabidopsis* lines are more sensitive to salt and ER stress ([@B15]). The observed salt tolerance of the *ubc32* mutant is in contrast to the reduced salt tolerance of other known *Arabidopsis* ERAD mutants, including *ebs5/hrd3a*, *ebs6/os9*, and *hrd1ahrd1b* ([@B57]; [@B42]; [@B43]). This discrepancy might be explained by different ERAD substrates being degraded by different E3 ligase complexes: ERAD~L/M~ substrates by AtHrd1A/AtHrd1B in association with cytosolic E2s and ERAD~C~ substrates by Doa10 using membrane-anchored E2s. Indeed, UBC32 was found to interact with *Arabidopsis* Doa10B and to stimulate the ubiquitination and degradation of a known ERAD substrate MLO-12, another variant of MLO carrying a single amino acid change in its cytosolic domain ([@B67]), in a tobacco leaf transient expression experiment ([@B15]). However, the tobacco result was quite different from the results obtained with the yeast MLO experiment showing that the ERAD of MLO-12 plus two other mutant MLOs (all carrying a cytosolic mutation) used the Ubc7-Hrd1 pathway but was unaffected by either *ubc6* or *doa10* deletion in yeast ([@B67]). Such inconsistency might be simply caused by heterologous expression of ERAD~C~ substrates in two different eukaryotic systems. Nevertheless, UBC32 was implicated in the Hrd1-mediated degradation of bri1-9 (a presumed ERAD~L~ substrate) as the *ubc32* mutation partially inhibited the degradation of the mutant BR receptor and weakly suppressed the corresponding dwarf phenotype ([@B15]). The partial inhibition could be attributed to a redundant role of UBC32 with its two close homologs or the potential *Arabidopsis* homologs of Ubc1/Ubc7. However, blast searches failed to find a single homolog of the yeast *Cue1* gene from published sequences of plant genomes and expressed sequence tags (our unpublished results), suggesting that plant ERAD processes might exclusively rely on ER-anchored membrane E2s. Alternatively, plants could recruit cytosolic E2s to the membrane-anchored E3 complexes via yet unknown recruiting factors that share no sequence homology but are functionally similar to Cue1.

The ubiquitination of ERAD substrates, especially those lacking *N*-glycan degradation signals, by the Hrd1 complex requires two additional adapters: U1-Snp1 associating-1 (Usa1; HERP in mammals), an ER membrane protein containing a ubiquitin-like (UBL) motif near it N-terminus and two predicted transmembrane domains in the middle, and Der1 (degradation in the ER; Derlins for Der1-like proteins in mammals), another integral ER membrane protein with four transmembrane segments ([@B50]). Usa1 is thought to regulate the stability and/or oligomerization of Hrd1 and to recruit Der1 to the Hrd1 complex ([@B12], [@B13]; [@B37]; [@B11]), while Der1 is believed to function either as a receptor for soluble non-glycosylated ERAD substrates or a potential retrotranslocation channel ([@B56]; [@B101]; [@B48]). The *Arabidopsis* contains no homolog of Usa1/HERP1 but its genome encodes three Der1 homologs whose functional involvement in a plant ERAD pathway awaits detailed genetic and biochemical investigations ([@B49]). An earlier study showed that at least two maize Der1 homologs could complement the yeast Δ *der1* mutant, suggesting a potential role for a plant Der1 homolog in an ERAD pathway; however, there is no genetic evidence for proving the hypothesis ([@B49]).

RETROTRANSLOCATION OF ERAD SUBSTRATES
=====================================

Because the catalytic domains of the ERAD-participating E2s and E3s are on the cytosolic surface of the ER membrane, ERAD substrates need to undergo retrotranslocation for ubiquitination and to access the cytosolic proteasome system for their degradation. However, the molecular nature of this retrotranslocon remains controversial ([@B29]). It was previously thought that the Sec61 translocon, which imports nascent polypeptides into the ER lumen during protein biosynthesis, is responsible for retrotranslocation ERAD substrates through the ER membrane ([@B76]; [@B77]). Other studies suggested that the yeast Der1 and its mammalian orthologs Derlins are the suspected retrotranslocon ([@B56]; [@B101]). A recent study, however, showed that the E3 ligase Hrd1 itself could serve as the retrotranslocation channel for ERAD~L~ substrates ([@B13]). It is quite possible that all three proteins are capable of retrotranslocation different ERAD substrates involving different adapter proteins.

Compared to the knowledge gained from the yeast and mammalian studies, we know almost nothing about the retrotranslocation step of a plant ERAD pathway. Several earlier studies did suggest the existence of a retrotranslocon in plant cells to move ERAD substrates into the cytosol. A confocal microscopic analysis of subcellular localization of a fusion protein between green fluorescent protein (GFP) with the P-domain of a maize CRT in tobacco leaf protoplasts suggested a retrotransport route from the ER to the cytosol ([@B8]). In addition, a series of studies revealed that the A chain (known as RTA) of a ribosome-inactivating toxin, ricin that is normally produced as a dimeric protein of RTA covalently linked to a galactose-binding B chain via a single intramolecular disulfide bond and stored in the central vacuole of the endosperm cells of castor bean (*Ricinus communis*), was detected to be deglycosylated and eventual degraded in the cytosol when expressed alone in tobacco leaf protoplasts ([@B18], [@B19]; [@B61]). It is important to mention that ricin and a few other plant toxins were known to exploit the ERAD pathway to reach their cytosolic targets after being internalized by mammalian cells and retrograde-transported from the cell surface to the ER ([@B58]). In both yeast and mammalian systems, retrotranslocation of ERAD substrates was driven by ubiquitination ([@B6]); however, a recent RTA study using plant protoplasts showed that retrotranslocation is independent of ubiquitination as the lysine-lacking (hence non-ubiquitinated) variant of RTA could still be retrotranslocated from the ER into the cytosol ([@B19]), suggesting that the ubiquitination-retrotranslocation coupling might be substrate-dependent.

SUBSTRATE EXTRACTION, PROCESSING, AND DELIVERY TO THE PROTEASOME
================================================================

Without regard to the identity of the actual retrotranslocons, ubiquitinated ERAD clients are extracted from the ER lumen (ERAD~L~ substrates) or ER membrane (ERAD~M/C~ substrates) by a trimeric complex consisting of a homohexameric Cdc48 (p97 or valosin-containing protein in mammals), an AAA-type ATPase and its two substrate-recruiting factors Ufd1 and Npl4 (each having a ubiquitin-binding domain; [@B99]). The (CDC48)~6~-Ufd-Npl4 complex itself is recruited to the Hrd1/Doa10 E3 complexes by Ubx2 (VIMP for p97/VCP-interacting membrane protein in mammals), one of the 7 ubiquitin regulatory X (UBX) domain-containing proteins in yeast (13 UBX proteins in mammals; [@B69]; [@B86], [@B87]). The current working model posits that extracted ERAD substrates are further processed through antagonistic interactions between an U-box-containing E4 multiubiquitination enzyme Ufd2 and a WD40 repeat-containing protein Ufd3 with unknown enzyme activity plus a deubiquitylating enzyme Otu1, and/or through deglycosylation by the cytoplasmic peptide:*N*-glycanase (PNGase) Png1 ([@B80]). The processed ERAD substrates were subsequently delivered to the cytosolic proteasome by Cdc48 in association with two ubiquitin receptors Rad23 and Dsk2, each containing a UBL domain that interacts directly with the cytosolic proteasome and a polyubiquitin-interacting ubiquitin-associated (UBA) domain ([@B80]).

The *Arabidopsis* genome encodes three Cdc48 homologs, AtCDC48A, AtCDC48B, and AtCDC48C ([@B81]). AtCDC48A was able to complement a yeast *cdc48* mutant ([@B23]) and was shown to play a role in the ERAD of a mutant form of MLO and a mutant variant of the *Arabidopsis* vacuolar carboxypeptidase carrying the same Gly-Arg mutation as the yeast CPY\* and in the retrotranslocation of RTA and the orphan subunit (RCA A) of another castor bean toxin agglutinin in plant cells ([@B67]; [@B61]; [@B100]). AtCDC48A is likely to be recruited to the ER membrane by UBX-containing proteins as the *Arabidopsis* genome encodes a total of 15 UBX-containing proteins (known as AtPUXs; **Table [1](#T1){ref-type="table"}**), some of which were shown to interact with AtCDC48A ([@B82]; [@B73]). It remains to be determined which of the 15 AtPUX proteins are actually involved in recruiting an AtCDC48 to the ER membrane-anchored E3 ligase complexes and play a role in degrading known plant ERAD substrates. Our BLAST searches using the known ERAD components of yeast and mammals as query identified multiple homologs of the Ufd1, Ufd2, Ufd3, Npl4, Rad23, Dsk2 but only a single PNGase homolog in *Arabidopsis* (**Table [1](#T1){ref-type="table"}**). The functional involvement of these potential ERAD components in an *Arabidopsis* ERAD process remains unknown except AtPNG1, which was recently shown to contain the suspected PNGase activity and could stimulate the degradation of two mutant variants of RTA in an *N*-glycan-dependent manner in yeast cells ([@B20]; [@B62]).

CONCLUSION AND CHALLENGES
=========================

Despite rapid progress in recent years for identifying molecular components of plant ERQC/ERAD systems and studying their biochemical functions, our understanding of the plant ERQC/ERAD processes remains rather limited, especially about the later stages of the ERAD pathway, such as retrotranslocation, processing of polyubiquitin chains, and delivery (to cytosolic proteasome) of the known plant ERAD substrates. While forward genetic screens in *Arabidopsis* identified the GII-UGGT-mediated CNX/CRT cycle in retaining incomplete/mis-folded glycoproteins and ERAD components that function inside the ER lumen to promote the degradation of the two mutant BR receptors, reverse genetic approaches using T-DNA insertional mutants or RNAi-mediated knockdown of candidate ERAD genes listed in **Table [1](#T1){ref-type="table"}** will certainly provide additional knowledge on the plant ERAD mechanisms. Transgenic *Arabidopsis* lines expressing carefully engineered substrates of glycosylated/non-glycosylated ERAD~C~/ERAD~M~ coupled with forward genetic screens and reverse genetic studies will reveal if *Arabidopsis* has several distinct ERAD subpathways using different E3 ligases and adapter proteins that recruits distinct ERAD clients. Similarly, genetic screens for enhancers/suppressors of the *Arabidopsis* wax mutant *cer9* \[defective in Doa10A ([@B59])\] or *drought hypersensitive 2* mutant \[that led to independent discovery of Doa10A ([@B21])\] could uncover additional ERAD components, reveal unique features of the plant ERAD processes, and a better understanding of the regulatory function of the plant ERAD system in biosynthetic processes. Proteomic studies with the existing *Arabidopsis* mutants of the ERAD E3 ligases could lead to the discovery of additional biochemical pathways and/or physiological processes regulated by the plant ERAD machinery. However, the biggest challenges for the plant ERQC/ERAD research is whether the forward genetic approach in *Arabidopsis* could identify novel ERQC/ERAD components that haven't been discovered in other eukaryotic systems and if the combination of the *Arabidopsis* genetics with cutting-edge biochemical studies in *Arabidopsis* and transient expression systems could reveal novel biochemical functions of known or predicted ERAD components and provide satisfactory answers to some of the outstanding questions of the general ERQC/ERAD research field.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

[^1]: Edited by: *Stephen H. Howell, Iowa State University, USA*

[^2]: Reviewed by: *Richard Strasser, University of Natural Resources and Life Sciences, Austria; Stephen H. Howell, Iowa State University, USA*

[^3]: This article was submitted to Plant Cell Biology, a section of the journal Frontiers in Plant Science.
